PHARMACOSMOS A/S
Credit rating
Company information
About PHARMACOSMOS A/S
PHARMACOSMOS A/S (CVR number: 15517085) is a company from HOLBÆK. The company reported a net sales of 1613.1 mDKK in 2023, demonstrating a growth of 46.1 % compared to the previous year. The operating profit percentage was at 42.1 % (EBIT: 679.5 mDKK), while net earnings were 789.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 34.8 %, which can be considered excellent and Return on Equity (ROE) was 63.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 61.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PHARMACOSMOS A/S's liquidity measured by quick ratio was 3.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 609.06 | 782.21 | 876.81 | 1 104.17 | 1 613.14 |
Gross profit | 328.86 | 464.89 | 545.46 | 700.85 | 1 245.36 |
EBIT | 128.28 | 219.34 | 210.95 | 272.23 | 679.52 |
Net earnings | 59.60 | - 118.52 | 170.04 | 114.27 | 789.70 |
Shareholders equity total | 894.44 | 670.68 | 807.47 | 854.59 | 1 635.78 |
Balance sheet total (assets) | 1 354.81 | 1 478.56 | 1 590.17 | 1 753.45 | 2 657.70 |
Net debt | 96.87 | - 167.70 | |||
Profitability | |||||
EBIT-% | 21.1 % | 28.0 % | 24.1 % | 24.7 % | 42.1 % |
ROA | 9.6 % | 15.5 % | 13.7 % | 15.9 % | 34.8 % |
ROE | 6.9 % | -15.1 % | 23.0 % | 13.8 % | 63.4 % |
ROI | 9.6 % | 15.5 % | 13.7 % | 16.6 % | 37.1 % |
Economic value added (EVA) | 86.36 | 174.39 | 177.25 | 168.29 | 505.85 |
Solvency | |||||
Equity ratio | 100.0 % | 100.0 % | 100.0 % | 48.7 % | 61.5 % |
Gearing | 88.9 % | 54.0 % | |||
Relative net indebtedness % | 20.8 % | -1.8 % | |||
Liquidity | |||||
Quick ratio | 2.8 | 3.4 | |||
Current ratio | 3.1 | 3.6 | |||
Cash and cash equivalents | 662.56 | 1 051.17 | |||
Capital use efficiency | |||||
Trade debtors turnover (days) | 37.6 | 53.5 | |||
Net working capital % | 72.9 % | 53.6 % | |||
Credit risk | |||||
Credit rating | BBB | AA | A |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.